Name | Value |
---|---|
Revenues | 1,807.0K |
Cost of Revenue | 1,518.0K |
Gross Profit | 289.0K |
Operating Expense | 1,657.0K |
Operating I/L | -1,368.0K |
Other Income/Expense | 56.0K |
Interest Income | 56.0K |
Pretax | -1,312.0K |
Income Tax Expense | 4.0K |
Net Income/Loss | -1,316.0K |
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens for various diseases and medical complications, as well as to measure specific substances in the body at extremely small concentrations. Its products cater to gastrointestinal diseases, food intolerances, diabetes, and esoteric tests, selling primarily through physicians' offices, over-the-counter drugstores, and hospital/clinical laboratories. Additionally, the company is developing irritable bowel syndrome therapy technology, diagnostic-guided therapy, Helicobacter pylori products, and diagnostic products for COVID-19 infection.